Wedbush Edward William is Buying Versar Inc. (NYSEMKT:VSR) Shares

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC),...
Stay Ahead of the
Stock Market Game!
Subscribe to Small Cap
Exclusive for more

trending

Cesca Therapeutics Inc. (NASDAQ:KOOL) is Attracting ...
Here's Who Just Picked Up Entellus Medical Inc. (NAS...
Ocera Therapeutics Inc. (NASDAQ:OCRX) is Attracting ...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Versar Inc. (NYSEMKT:VSR) reported that Wedbush Edward William has picked up 218,268  of common stock as of 2017-02-15.

The acquisition brings the aggregate amount owned by Wedbush Edward William to a total of 218,268 representing a 2.2% stake in the company.

For those not familiar with the company, Versar, Inc. is a global project management company providing solutions to government and commercial clients primarily in three business segments: Engineering and Construction Management (ECM), Environmental Services (ESG), and Professional Services (PSG). The Company also provides tailored solutions in harsh environments and offers specialized abilities for classified projects and hazardous materials management. ECM performs Title I Design Services, Title II Construction Management Services and Title III Construction Services. ESG provides full service environmental solutions for project life cycles ranging from a few weeks to more than 15 years in duration and includes Remediation, Compliance, Natural Resources, Cultural Resources, and Unexploded Ordnance/Military Munitions Response Program (UXO/MMRP) Technical Service Areas (TSAs). PSG provides onsite environmental management, planning and engineering services to the Department of Defense (DOD) installations.

A glance at Versar Inc. (NYSEMKT:VSR)’s key stats reveals a current market capitalization of 9.12 million based on 9.89 million shares outstanding and a price at last close of $0.930 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2016-02-17, Otten picked up 100 at a purchase price of $2.34. This brings their total holding to 119,446 as of the date of the filing.

On the sell side, the most recent transaction saw Cooper unload 3,682 shares at a sale price of $3.30. This brings their total holding to 5,743.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Versar Inc. (NYSEMKT:VSR) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

 

 

Stay in the lopp :

CytoDyn (CYDY) Stock Extends Fall: Fall Anoth...

For the past couple of years, biotech firm CytoDyn (OTCMKTS:CYDY) has come into prominence due to its work with leronlimab, which is known

FULL DISCLAIMER - CNTM
Why Pharmacyte Biotech Inc (OTCMKTS:PMCB) Sha...
Pharmacyte Biotech Inc (OTCMKTS:PMCB) shares were down 13.04% on Wednesday but recovered 1.39% in after-hours trading. Share prices have been trading in a 52-week

related post

Skip to content